vs
Side-by-side financial comparison of Duolingo, Inc. (DUOL) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $295.5M, roughly 1.7× Duolingo, Inc.). Duolingo, Inc. runs the higher net margin — 11.9% vs 6.8%, a 5.1% gap on every dollar of revenue. On growth, Duolingo, Inc. posted the faster year-over-year revenue change (27.0% vs -1.7%). Over the past eight quarters, Duolingo, Inc.'s revenue compounded faster (28.7% CAGR vs -0.1%).
Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DUOL vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.5M | $493.8M |
| Net Profit | $35.1M | $33.7M |
| Gross Margin | 55.5% | — |
| Operating Margin | 8.0% | 9.9% |
| Net Margin | 11.9% | 6.8% |
| Revenue YoY | 27.0% | -1.7% |
| Net Profit YoY | 24.0% | 10.5% |
| EPS (diluted) | $0.72 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.5M | — | ||
| Q4 25 | $282.9M | $493.8M | ||
| Q3 25 | $271.7M | $492.9M | ||
| Q2 25 | $252.3M | $468.8M | ||
| Q1 25 | $230.7M | $458.4M | ||
| Q4 24 | $209.6M | $502.4M | ||
| Q3 24 | $192.6M | $511.2M | ||
| Q2 24 | $178.3M | $504.3M |
| Q1 26 | $35.1M | — | ||
| Q4 25 | $42.0M | $33.7M | ||
| Q3 25 | $292.2M | $71.7M | ||
| Q2 25 | $44.8M | $39.3M | ||
| Q1 25 | $35.1M | $20.7M | ||
| Q4 24 | $13.9M | $30.5M | ||
| Q3 24 | $23.4M | $19.4M | ||
| Q2 24 | $24.4M | $-153.0M |
| Q1 26 | 55.5% | — | ||
| Q4 25 | 72.8% | — | ||
| Q3 25 | 72.5% | — | ||
| Q2 25 | 72.4% | — | ||
| Q1 25 | 71.1% | — | ||
| Q4 24 | 71.9% | — | ||
| Q3 24 | 72.9% | — | ||
| Q2 24 | 73.4% | — |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 15.4% | 9.9% | ||
| Q3 25 | 12.9% | 13.8% | ||
| Q2 25 | 13.2% | 12.8% | ||
| Q1 25 | 10.2% | 7.0% | ||
| Q4 24 | 6.6% | 7.8% | ||
| Q3 24 | 7.0% | 6.6% | ||
| Q2 24 | 10.5% | -31.3% |
| Q1 26 | 11.9% | — | ||
| Q4 25 | 14.8% | 6.8% | ||
| Q3 25 | 107.5% | 14.5% | ||
| Q2 25 | 17.8% | 8.4% | ||
| Q1 25 | 15.2% | 4.5% | ||
| Q4 24 | 6.6% | 6.1% | ||
| Q3 24 | 12.1% | 3.8% | ||
| Q2 24 | 13.7% | -30.3% |
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.99 | $0.40 | ||
| Q3 25 | $5.95 | $0.84 | ||
| Q2 25 | $0.91 | $0.46 | ||
| Q1 25 | $0.72 | $0.24 | ||
| Q4 24 | $0.31 | $0.37 | ||
| Q3 24 | $0.49 | $0.23 | ||
| Q2 24 | $0.51 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $1.3B | $865.9M |
| Total Assets | $2.0B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.0B | $375.2M | ||
| Q3 25 | $1.0B | $340.1M | ||
| Q2 25 | $976.2M | $224.7M | ||
| Q1 25 | $884.0M | $99.0M | ||
| Q4 24 | $785.8M | $229.9M | ||
| Q3 24 | $854.4M | $103.8M | ||
| Q2 24 | $888.2M | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $865.9M | ||
| Q3 25 | $1.3B | $890.7M | ||
| Q2 25 | $977.0M | $833.8M | ||
| Q1 25 | $893.8M | $789.2M | ||
| Q4 24 | $824.5M | $764.9M | ||
| Q3 24 | $822.5M | $732.5M | ||
| Q2 24 | $766.9M | $706.5M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.2B | ||
| Q3 25 | $1.9B | $2.2B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.1B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.6M | $114.1M |
| Free Cash FlowOCF − Capex | $103.0M | — |
| FCF MarginFCF / Revenue | 34.9% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.01× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $368.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $105.6M | — | ||
| Q4 25 | $107.3M | $114.1M | ||
| Q3 25 | $84.2M | $137.3M | ||
| Q2 25 | $90.7M | $137.2M | ||
| Q1 25 | $105.6M | $-117.5M | ||
| Q4 24 | $83.3M | $133.0M | ||
| Q3 24 | $56.3M | $91.8M | ||
| Q2 24 | $62.4M | $107.0M |
| Q1 26 | $103.0M | — | ||
| Q4 25 | $96.6M | — | ||
| Q3 25 | $79.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $104.3M | — | ||
| Q4 24 | $81.4M | — | ||
| Q3 24 | $53.1M | — | ||
| Q2 24 | $56.8M | — |
| Q1 26 | 34.9% | — | ||
| Q4 25 | 34.1% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 35.5% | — | ||
| Q1 25 | 45.2% | — | ||
| Q4 24 | 38.8% | — | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | 31.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 3.1% | — |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.56× | 3.39× | ||
| Q3 25 | 0.29× | 1.91× | ||
| Q2 25 | 2.02× | 3.49× | ||
| Q1 25 | 3.01× | -5.66× | ||
| Q4 24 | 5.99× | 4.36× | ||
| Q3 24 | 2.41× | 4.72× | ||
| Q2 24 | 2.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DUOL
| Bookings | $283.5M | 96% |
| Other | $12.0M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
